Back to today’s briefing

Story perspectives

Telehealth and GLP-1 Medications Transform Alcohol Treatment Access

5/2/2025

50 10

Summary

Story summary

Only 2% of patients with alcohol use disorder (AUD) receive FDA-approved treatments like naltrexone, largely due to stigma and hesitance from doctors. Telehealth platforms such as Oar Health are stepping in to break down these barriers. Excitingly, new studies indicate that GLP-1 medications could also play a role in treating AUD, emphasizing the urgent need for more research and awareness.

1 of 1

Story summary

Only 2% of patients with alcohol use disorder (AUD) receive FDA-approved treatments like naltrexone, largely due to stigma and hesitance from doctors. Telehealth platforms such as Oar Health are stepping in to break down these barriers. Excitingly, new studies indicate that GLP-1 medications could also play a role in treating AUD, emphasizing the urgent need for more research and awareness.